Kryptos Biotechnologies Secures $10 Mil in Series A Funding | Funds to Be Used for Clinical Studies and FDA Approval of their Molecular Diagnostics System
Strategic Investor, Osang Healthcare will partner with Kryptos Biotechnologies for the manufacturing and distribution of the product along with financing.